Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

ANNX vs CRVS: stock comparison and AI forecast

Annexon, Inc. (ANNX) and Corvus Pharmaceuticals, Inc. (CRVS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

ANNX Annexon, Inc.

Market Cap
$794M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

CRVS Corvus Pharmaceuticals, Inc.

Price
$9.83 -37.4% · 6M
Market Cap
$827M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

ANNX · CRVS

Key facts

  • ANNX and CRVS have similar market capitalizations ($794M and $827M).
  • ANNX carries 0.31 times debt per unit of equity, against 0.06 times for CRVS.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricANNXCRVS
Market Cap$794M$827M
P/B Ratio3.75x3.67x
EPS$-1.28$-0.62
Book Value/Share$1.12$2.68
FCF/Share$-1.02$-0.54

Profitability & Margins

MetricANNXCRVS
ROE-91.4%-24.0%
ROA–-22.6%
ROIC–-25.2%
Tax Rate–0.0%

Financial Health

MetricANNXCRVS
Current Ratio5.53x16.16x
D/E Ratio0.31x0.06x
Financial Leverage–1.06x
Working Capital$174M$207M

Cash Flow

MetricANNXCRVS
Operating Cash Flow-$193M-$45M
Free Cash Flow-$193M-$45M
Capital Spending-$180K-$700K

Income Statement

MetricANNXCRVS
Operating Income-$211M-$57M
Net Income-$193M-$54M
R&D Expense$175M$46M

Dividend & Shareholder Information

MetricANNXCRVS
Shares Outstanding190M84M
FAQ

ANNX vs CRVS: stock comparison and AI forecast

Which is bigger, ANNX or CRVS?

ANNX and CRVS have similar market capitalizations ($794M and $827M).

Which one does Intratio's AI model rank higher, ANNX or CRVS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.